Blog

Our Women in Technology series continues with Elena Tanturovska, QA Automation Engineer.

Registry studies focused on a specific medical device are a valuable tool to capture the safety and outcomes of the device over its lifetime. Read more here.

Hoboken, New Jersey: March 10, 2021: Castor, a leading provider of clinical trial technology, today announced the signing…

In the Castor D&I interview series, Castorian women in technology share their experiences and thoughts on making the workplace more inclusive.

Castor’s most significant core value is “Achieve anything with a happy and healthy Team,” and so we wanted to ensure we embrace this value even more in a remote-first set-up where employees are not regularly coming into a shared working space.

COVID-19 changed the conversation around enrollment and recruitment for clinical trials. Learn how eConsent is helping researchers do more despite restrictions.

Hoboken, New Jersey: December 17, 2020: Castor, a leading provider of clinical trial technology, today announced the launch…

In September 2020, Castor CEO Derk Arts, MD, Ph.D., led a webinar on electronic informed consent (eConsent) challenges…

Industry veterans from leading life sciences companies including Johnson & Johnson, Biogen, and Medtronic, will support the Company’s…

In the wake of Brexit, medical device companies secure a UKCA mark as proof of conformity to place their device on the UK market. Learn what this means for your organization and how to prepare.